Currently out of the existing stock ratings of Naureen Quibria, 11 are a BUY (100%).

Naureen Quibria

Work Performance Price Targets & Ratings Chart

Analyst Naureen Quibria, has had 10% of price targets met with an average potential upside of 44.52%, reached in 182 days on average. Previously, Naureen Quibria worked at CAPITAL ONE, MAXIM GROUP.

Naureen Quibria has documented 23 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ADCT, ADC Therapeutics SA at 14-Sep-2023.

Wall Street Analyst Naureen Quibria

Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) on 9/7/2022. The price target of $7 was fulfilled within 910 days with a profit of $4.83 (222.58%), with a performance score of 2.45.

Average potential price target upside

CRDF Cardiff Oncology AYLA Ayala Pharmaceuticals ONCR Oncorus CMRX Chimerix ADCT ADC Therapeutics SA

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Sep-2026

$9

$7.92 (733.33%)

2 months 7 days ago
(15-Sep-2026)

0/3 (0%)

$7.66 (571.64%)

Buy Since 06-Sep-2024

$2

$0.92 (85.19%)

$8

5 months 19 days ago
(03-Jun-2026)

0/2 (0%)

$0.6 (42.86%)

Buy Since 22-Oct-2020

$10

$8.92 (825.93%)

$10

7 months 2 days ago
(20-Apr-2026)

0/10 (0%)

$8.22 (461.80%)

Buy Since 14-Apr-2025

$6

$4.92 (455.56%)

$10

8 months 28 days ago
(25-Feb-2026)

0/2 (0%)

$4.09 (214.14%)

Buy Since 08-Oct-2020

$10

1 years 11 months 9 days ago
(13-Dec-2024)

0/5 (0%)

$6.08 (155.10%)

Show more analysts

Stocks Naureen Quibria covered previously. Scores are shown for active stocks only.

CM Canadian Imperial Bank Of Commerce IMMP Immutep Ltd ADR KZIA Kazia Therapeutics Ltd ADR ONCT Oncternal Therapeutics

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?